NYSE: NVONovo Nordisk A S Stock Ownership - Who owns Novo Nordisk (Ozempic)?
Insider buying vs selling
Have Novo Nordisk A S insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when NVO insiders and whales buy or sell their stock.
NVO Shareholders
What type of owners hold Novo Nordisk A S stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jennison Associates LLC | 0.45% | 19,944,809 | $1.16B | Institution |
| Bank Of America Corp | 0.35% | 15,492,384 | $903.67M | Institution |
| Gqg Partners LLC | 0.29% | 12,994,533 | $757.97M | Institution |
| Fisher Asset Management LLC | 0.28% | 12,640,489 | $737.32M | Institution |
| Morgan Stanley | 0.27% | 12,204,292 | $711.88M | Institution |
| Loomis Sayles Co L P | 0.26% | 11,571,686 | $674.98M | Institution |
| Fayez Sarofim Co | 0.25% | 11,384,481 | $664.06M | Institution |
| Fmr LLC | 0.22% | 10,021,884 | $584.58M | Institution |
| Folketrygdfondet | 0.20% | 8,903,938 | $519.37M | Institution |
| Renaissance Technologies LLC | 0.19% | 8,312,996 | $484.90M | Institution |
NVO vs Biotech Stocks
Novo Nordisk (Ozempic) Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.